Analysis Of the Concept of Self-Care In Multidrug Resistance Tuberculosis (MDR-TB) Patients
Andy Setiawan, Pramudya Pramudya, Hasyrin Ainun
Advances in health sciences research/Advances in Health Sciences Research · 2024-01
Abstract
Multidrug-resistant tuberculosis (MDR-TB) represents a strain of TB bacteria that exhibits resistance to a minimum of two primary anti-TB medications: Isoniazid and Rifampicin, both of which are regarded as the most potent drugs for combating TB.The management of drug-resistant TB is slated to be included in the national TB control program.MDR-TB cases continue to rise.Clinical management of MDR-TB is more complicated than sensitive TB because it uses line I and line II anti-TB drugs, causing tolerance problems and side effects.Tuberculosis Multidrug Resistance (MDR TB) is a tuberculosis (TB) disease that has experienced resistance to isoniazid (INH) and rifampicin as well as one or more anti-tuberculosis drugs (OAT).One of the things that affect the decline in body power is the influence of selfcare patterns where it is influenced by internal and external factors.The purpose of this article is to identify internal and external factors that influence self-care patterns in MDR-TB clients.A concept analysis approach is used to analyze the concept of self-care.The four definitions of self-care are diet, regular physical exercise, regular medication monitoring, and self-care to prevent complications from poor self-care.The antecedent of self-care of MDR-TB patients has two factors, namely internal and external.Internal factors include; age, gender, knowledge, and attitude.External factors include; education, economic level, family support, and the role of health workers.The consequences of self-care can increase the success of recovery and improve quality of life.The conclusion of this concept is to increase nurses' knowledge about self-care in MDR-TB patients who carry out treatment so that it is expected to develop evidence-based nursing.
MeSH terms
- Tuberculosis
- Medicine
- Isoniazid
- Rifampicin
- Disease
- Multiple drug resistance
- Multi-drug-resistant tuberculosis
- Intensive care medicine
- Drug resistance
- Health care
- Internal medicine
- Family medicine
- Mycobacterium tuberculosis